Annals
Established in 1927 by the American College of Physicians
:
Advanced search
 
box Article
 arrow  Correction
space
 arrow  Table of Contents                
space
 arrow  Full Text of this article
space
 arrow  PDF of this article
(PDFs free after 6 months)
space
 arrow  Summary for Patients
space
 arrow  Figures/Tables List
space
 arrow  Related articles in Annals
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box PubMed
Articles in PubMed by Author:
  arrow  Krumholz, H. M.
space
  arrow  Marciniak, T. A.
space
 arrow  Related Articles in PubMed
space
 arrow  PubMed Citation
space
 arrow  PubMed
space

ARTICLE

Early ß-Blocker Therapy for Acute Myocardial Infarction in Elderly Patients

right arrow Harlan M. Krumholz, MD; Martha J. Radford, MD; Yun Wang, MS; Jersey Chen, BA; and Thomas A. Marciniak, MD

2 November 1999 | Volume 131 Issue 9 | Pages 648-654

Background: Despite the evidence supporting the importance of early ß-blocker therapy, this intervention has received little attention as an indicator of quality of care.

Objectives: To determine how often ß-blockers are administered as early treatment of acute myocardial infarction in patients 65 years of age or older, to identify predictors of the decision to use ß-blockers, and to evaluate the association between the early use of ß-blockers and in-hospital mortality.

Design: Observational study.

Setting: Nongovernment, acute care hospitals in the United States.

Patients: Medicare beneficiaries who were 65 years of age or older, were hospitalized with an acute myocardial infarction in 1994 and 1995, and did not have a contraindication to ß-blocker therapy.

Measurements: Medical chart review to obtain information about the use of ß-blockers, contraindications to these drugs, patient demographics, and clinical factors.

Results: Of the 58 165 patients (from a total of 4414 hospitals), 28 256 (49%) received early ß-blocker therapy. Patients with the highest risk for in-hospital death were the least likely to receive therapy. Patients who received ß-blockers had a lower in-hospital mortality rate than patients who did not receive ß-blockers (odds ratio, 0.81 [95% CI, 0.75 to 0.87]), even after adjustment for baseline differences in demographic, clinical, and treatment characteristics between the two groups.

Conclusions: Early ß-blocker therapy was not used for 51% of elderly patients who were hospitalized with an acute myocardial infarction and did not have a contraindication to this therapy. Increasing the early use of ß-blockers for these patients would provide an excellent opportunity to improve their care and outcomes.

Author and Article Information
space

From Yale University School of Medicine and the Yale-New Haven Hospital Center for Outcomes Research and Evaluation, New Haven, Connecticut; and the Health Care Financing Administration, Baltimore, Maryland.

Grant Support: Dr. Krumholz is a Paul Beeson Faculty Scholar. The analyses on which this report is based were performed under contract 500-96-P549, titled "Utilization and Quality Control Peer Review Organization for the State of Connecticut," sponsored by the Health Care Financing Administration, Department of Health and Human Services. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, and the mention of trade names, commercial products, or organizations does not imply endorsement by the U.S. Government. The authors assume full responsibility for the accuracy and completeness of the ideas presented. This article is a direct result of the Health Care Quality Improvement Program initiated by the Health Care Financing Administration, which has encouraged identification of quality improvement projects derived from analysis of patterns of care and therefore required no special funding on the part of this Contractor. Ideas and contributions to the authors concerning experience in engaging with issues presented are welcomed.

Requests for Reprints: Harlan M. Krumholz, MD, Yale University School of Medicine, 333 Cedar Street, Room IE-61 SHM, New Haven, CT 06520-8025; e-mail, harlan.krumholz{at}yale.edu. For reprint orders in quantities exceeding 100, please contact the Reprints Coordinator; phone, 215-351-2657; e-mail, reprints{at}mail.acponline.org.

Current Author Addresses: Dr. Krumholz and Mr. Chen: Yale University School of Medicine, 333 Cedar Street, Room IE-61 SHM, New Haven, CT 06520-8025.

Dr. Radford: Center for Outcomes Research and Evaluation, Yale-New Haven Health System, 20 York Street, GB 415, New Haven, CT 06504.

Mr. Wang: Qualidigm, 100 Roscommon Drive, Middletown, CT 06457.

Dr. Marciniak: Health Care Financing Administration, 7500 Security Boulevard, Building S2-11-07, Baltimore, MD 21244-1850.


Related articles in Annals:

Summaries for Patients
Beta-blocker Medicines for Older People after Heart Attack
Annals 1999 131: 648. [Full Text]  

Letters
Correction: Missing Figure
Annals 2000 132: 167. [Full Text]  



This article has been cited by other articles:


Home page
J Am Coll Cardiol IntvHome page
H. M. Krumholz, E. H. Bradley, B. K. Nallamothu, H. H. Ting, W. B. Batchelor, E. Kline-Rogers, A. F. Stern, J. R. Byrd, and J. E. Brush Jr
A Campaign to Improve the Timeliness of Primary Percutaneous Coronary Intervention: Door-to-Balloon: An Alliance for Quality
J. Am. Coll. Cardiol. Intv., February 1, 2008; 1(1): 97 - 104.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
H. M. Krumholz
Guideline Recommendations and Results: The Importance of the Linkage
Ann Intern Med, September 4, 2007; 147(5): 342 - 343.
[Full Text] [PDF]


Home page
CirculationHome page
K. P. Alexander, L. K. Newby, P. W. Armstrong, C. P. Cannon, W. B. Gibler, M. W. Rich, F. Van de Werf, H. D. White, W. D. Weaver, M. D. Naylor, et al.
Acute Coronary Care in the Elderly, Part II: ST-Segment-Elevation Myocardial Infarction: A Scientific Statement for Healthcare Professionals From the American Heart Association Council on Clinical Cardiology: In Collaboration With the Society of Geriatric Cardiology
Circulation, May 15, 2007; 115(19): 2570 - 2589.
[Abstract] [Full Text] [PDF]


Home page
Am J Crit CareHome page
K. B. Keller and L. Lemberg
Secondary prevention of coronary artery disease in elderly persons: a treatise on a report by the american heart association.
Am. J. Crit. Care., September 1, 2006; 15(5): 514 - 518.
[Full Text] [PDF]


Home page
Qual Saf Health CareHome page
M Weiner, T E Stump, C M Callahan, J N Lewis, and C J McDonald
Pursuing integration of performance measures into electronic medical records: beta-adrenergic receptor antagonist medications
Qual. Saf. Health Care, April 1, 2005; 14(2): 99 - 106.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
T. A. Stukel, F. L. Lucas, and D. E. Wennberg
Long-term Outcomes of Regional Variations in Intensity of Invasive vs Medical Management of Medicare Patients With Acute Myocardial Infarction
JAMA, March 16, 2005; 293(11): 1329 - 1337.
[Abstract] [Full Text] [PDF]


Home page
Int J Qual Health CareHome page
I. A. Scott, C. P. Denaro, A. C. Hickey, C. Bennett, A. M. Mudge, D. C. Sanders, J. Thiele, and J. L. Flores
Optimising care of acute coronary syndromes in three Australian hospitals
Int. J. Qual. Health Care, August 1, 2004; 16(4): 275 - 284.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
P. K. Lindenauer, J. Fitzgerald, N. Hoople, and E. M. Benjamin
The Potential Preventability of Postoperative Myocardial Infarction: Underuse of Perioperative {beta}-Adrenergic Blockade
Arch Intern Med, April 12, 2004; 164(7): 762 - 766.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
A. D. Auerbach and J. Kleinbart
Update in Hospital Medicine
Ann Intern Med, March 2, 2004; 140(5): 363 - 369.
[Full Text] [PDF]


Home page
Arch Intern MedHome page
H. Silvet, F. Spencer, J. Yarzebski, D. Lessard, J. M. Gore, and R. J. Goldberg
Communitywide Trends in the Use and Outcomes Associated With {beta}-Blockers in Patients With Acute Myocardial Infarction: The Worcester Heart Attack Study
Arch Intern Med, October 13, 2003; 163(18): 2175 - 2183.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
D. R. Burwen, D. H. Galusha, J. M. Lewis, M. R. Bedinger, M. J. Radford, H. M. Krumholz, and J. M. Foody
National and State Trends in Quality of Care for Acute Myocardial Infarction Between 1994-1995 and 1998-1999: The Medicare Health Care Quality Improvement Program
Arch Intern Med, June 23, 2003; 163(12): 1430 - 1439.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
S. R. Salpeter, T. M. Ormiston, and E. E. Salpeter
Cardioselective {beta}-Blockers in Patients with Reactive Airway Disease: A Meta-Analysis
Ann Intern Med, November 5, 2002; 137(9): 715 - 725.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. Gheorghiade and S. Goldstein
{beta}-Blockers in the Post-Myocardial Infarction Patient
Circulation, July 23, 2002; 106(4): 394 - 398.
[Full Text] [PDF]


Home page
CirculationHome page
M. A. Williams, J. L. Fleg, P. A. Ades, B. R. Chaitman, N. H. Miller, S. M. Mohiuddin, I. S. Ockene, C. B. Taylor, and N. K. Wenger
Secondary Prevention of Coronary Heart Disease in the Elderly (With Emphasis on Patients >=75 Years of Age): An American Heart Association Scientific Statement From the Council on Clinical Cardiology Subcommittee on Exercise, Cardiac Rehabilitation, and Prevention
Circulation, April 9, 2002; 105(14): 1735 - 1743.
[Full Text] [PDF]


Home page
JAMAHome page
A. D. Auerbach and L. Goldman
{beta}-Blockers and Reduction of Cardiac Events in Noncardiac Surgery: Scientific Review
JAMA, March 20, 2002; 287(11): 1435 - 1444.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
A. D. Auerbach and L. Goldman
{beta}-Blockers and Reduction of Cardiac Events in Noncardiac Surgery: Clinical Applications
JAMA, March 20, 2002; 287(11): 1445 - 1447.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
S. B. Soumerai, T. J. McLaughlin, D. Ross-Degnan, C. L. Christiansen, and J. H. Gurwitz
Effectiveness of Thrombolytic Therapy for Acute Myocardial Infarction in the Elderly: Cause for Concern in the Old-Old
Arch Intern Med, March 11, 2002; 162(5): 561 - 568.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
M. Schmidt, P. K. Lindenauer, J. L. Fitzgerald, and E. M. Benjamin
Forecasting the Impact of a Clinical Practice Guideline for Perioperative {beta}-Blockers to Reduce Cardiovascular Morbidity and Mortality
Arch Intern Med, January 14, 2002; 162(1): 63 - 69.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
Measuring and Improving Quality of Care : A Report From the American Heart Association/American College of Cardiology First Scientific Forum on Assessment of Healthcare Quality in Cardiovascular Disease and Stroke
Stroke, April 1, 2000; 31(4): 1002 - 1012.
[Full Text] [PDF]


Home page
CirculationHome page
Measuring and Improving Quality of Care : A Report From the American Heart Association/American College of Cardiology First Scientific Forum on Assessment of Healthcare Quality in Cardiovascular Disease and Stroke
Circulation, March 28, 2000; 101(12): 1483 - 1493.
[Full Text] [PDF]


Home page
Journal Watch CardiologyHome page
Beta-Blockers Are Underused for Acute MI
Journal Watch Cardiology, December 17, 1999; 1999(1217): 3 - 3.
[Full Text]


Home page
JWatch GeneralHome page
Beta-Blockers Underused for Elderly with MI
Journal Watch (General), November 26, 1999; 1999(1126): 1 - 1.
[Full Text]




 Home | Current Issue | Past Issues | In the Clinic | ACP Journal Club | CME | Collections | Audio/Video | Mobile | Subscribe | Tools | Help | ACP Online 

Copyright © 1999 by the American College of Physicians.